Treatment of Parkinson disease (PD) with dopaminergic medication is associated with the development of impulse control disorders (ICDs). A new study suggests that, irrespective of medication, patients with PD are more likely to make impulsive decisions. How and why might the risk of ICDs be increased in patients with this disease?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
No effects of 1 Hz offline TMS on performance in the stop-signal game
Scientific Reports Open Access 18 July 2023
-
Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson’s disease
npj Parkinson's Disease Open Access 08 December 2021
-
Dopaminergic function and intertemporal choice
Translational Psychiatry Open Access 06 January 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Milenkova, M. et al. Intertemporal choice in Parkinson's disease. Mov. Disord. doi:10.1002/mds.23756
Housden, C. R., O'Sullivan, S. S., Joyce, E. M., Lees, A. J. & Roiser, J. P. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive–compulsive spectrum behaviors. Neuropsychopharmacology 35, 2155–2164 (2010).
Voon, V. et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl.) 207, 645–659 (2010).
Voon, V. et al. Impulse control disorders in Parkinson disease: a multicenter case–control study. Ann. Neurol. 69, 986–996 (2011).
Kobayashi, S. & Schultz, W. Influence of reward delays on responses of dopamine neurons. J. Neurosci. 28, 7837–7846 (2008).
Uslaner, J. M. & Robinson, T. E. Subthalamic nucleus lesions increase impulsive action and decrease impulsive choice—mediation by enhanced incentive motivation? Eur. J. Neurosci. 24, 2345–2354 (2006).
van Eimeren, T. et al. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology 34, 2758–2766 (2009).
Miyazaki, K., Miyazaki, K. W. & Doya, K. Activation of dorsal raphe serotonin neurons underlies waiting for delayed rewards. J. Neurosci. 31, 469–479 (2011).
van den Bergh, F. S., Bloemarts, E., Groenink, L., Olivier, B. & Oosting, R. S. Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and D-cycloserine. Pharmacol. Biochem. Behav. 8 5, 736–743 (2006).
Figner, B. et al. Lateral prefrontal cortex and self-control in intertemporal choice. Nat. Neurosci. 13, 538–539 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Voon, V., Dalley, J. Impulsive choice—Parkinson disease and dopaminergic therapy. Nat Rev Neurol 7, 541–542 (2011). https://doi.org/10.1038/nrneurol.2011.139
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.139
This article is cited by
-
No effects of 1 Hz offline TMS on performance in the stop-signal game
Scientific Reports (2023)
-
Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson’s disease
npj Parkinson's Disease (2021)
-
Dopaminergic function and intertemporal choice
Translational Psychiatry (2015)
-
Deep Brain Stimulation of the Subthalamic Nucleus, but not Dopaminergic Medication, Improves Proactive Inhibitory Control of Movement Initiation in Parkinson's Disease
Neurotherapeutics (2013)